Practical Guidance for the Use of Control‐IQ Technology During Physical Activity and Exercise
9 affiliations
- 1Endocrinology Unit University Hospital “Consorziale Policlinico” of Bari Bari Italy
- 2Endocrinology and Diabetes Unit Sant'Andrea University Hospital Rome Italy
- 3Pediatric Department Azienda Sanitaria Universitaria Friuli Centrale, Hospital of Udine Udine Italy
- 4Unit of Metabolic and Endocrine Disease “Centro Catanese di Medicina e Chirurgia” Clinic Catania Italy
- 5Department of Pediatrics, Pediatric Diabetology Unit IRCCS San Raffaele Scientific Institute, Vita‐Salute San Raffaele University Milan Italy
- 6School of Kinesiology and Health Science, Muscle Health Research Centre York University Toronto Canada
- 7Division of Endocrinology, Department of Pediatrics Stanford University Stanford California USA
- 8Exercise Physiology, Training and Training Therapy Research Group, Department of Human Movement Sciences, Sport & Health University of Graz Graz Austria
- 9Interdisciplinary Metabolic Medicine Trials Unit, Division of Endocrinology and Diabetology, Department of Internal Medicine Medical University of Graz Graz Austria
Abstract
Introduction: Use of automated insulin delivery (AID) systems during physical activity and exercise (PA) is safe and associated with improved glucose outcomes when compared with insulin pump therapy in manual mode and insulin pen therapy, provided that appropriate adjustments to insulin doses and carbohydrate intake are ensured.
Aim: This expert guidance aimed to support healthcare professionals in educating Control‐IQ (Tandem Diabetes Care) users on PA management.
Methods: Based on international recommendations, including the recent EASD/ISPAD position statement on AID and exercise, as well as on the authors' clinical experience, we developed practical flowcharts and accompanying information that provide step‐by‐step guidance for PA management in children, adolescents and adults with type 1 diabetes using the Control‐IQ technology.
Results: Operational instructions were outlined across four different scenarios, with additional advice on insulin pump suspension where required. In each of the scenarios, we highlighted the possibility of activating a Personal Profile with more or less insulin, a unique feature of the Control‐IQ algorithm that can be used simultaneously with the Exercise Activity feature.
Conclusion: We believe that this expert guidance, with its practical flowcharts, can help simplify decision‐making for Control‐IQ users.
Related
- The theoretical model and practical pattern of flow experience on college students’ willingness to adhere to physical exercise
- Editorial: Impacts of physical activity and exercise on metabolic disorders
- Influence of self-reported vascular health and physical activity level on intravoxel incoherent motion imaging response to exercise in chronic low back pain
- Recommendations for the development, implementation, and evaluation of technology-assisted physical activity interventions to support healthy aging: insights from PhysAgeNet
- Associations of regular physical exercise and total physical activity volume with the prevalence of abnormal glucose and lipid metabolism among community-dwelling older adults: a cross-sectional study
BibTeX
@article{molfetta2026practical,
title = {{Practical Guidance for the Use of Control‐IQ Technology During Physical Activity and Exercise}},
author = {Sergio Di Molfetta and Jonida Haxhi and Francesca Franco and Giuseppe Papa and Andrea Rigamonti and Michael C. Riddell and Dessi P. Zaharieva and Othmar Moser},
journal = {Diabetes, Obesity \& Metabolism},
year = {2026},
month = sep,
doi = {10.1111/dom.71350},
url = {https://doi.org/10.1111/dom.71350},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Practical Guidance for the Use of Control‐IQ Technology During Physical Activity and Exercise
AU - Sergio Di Molfetta
AU - Jonida Haxhi
AU - Francesca Franco
AU - Giuseppe Papa
AU - Andrea Rigamonti
AU - Michael C. Riddell
AU - Dessi P. Zaharieva
AU - Othmar Moser
PY - 2026
DA - 2026/09/14
JO - Diabetes, Obesity & Metabolism
DO - 10.1111/dom.71350
UR - https://doi.org/10.1111/dom.71350
AB - Introduction: Use of automated insulin delivery (AID) systems during physical activity and exercise (PA) is safe and associated with improved glucose outcomes when compared with insulin pump therapy in manual mode and insulin pen therapy, provided that appropriate adjustments to insulin doses and carbohydrate intake are ensured. Aim: This expert guidance aimed to support healthcare professionals in educating Control‐IQ (Tandem Diabetes Care) users on PA management. Methods: Based on international recommendations, including the recent EASD/ISPAD position statement on AID and exercise, as well as on the authors' clinical experience, we developed practical flowcharts and accompanying information that provide step‐by‐step guidance for PA management in children, adolescents and adults with type 1 diabetes using the Control‐IQ technology. Results: Operational instructions were outlined across four different scenarios, with additional advice on insulin pump suspension where required. In each of the scenarios, we highlighted the possibility of activating a Personal Profile with more or less insulin, a unique feature of the Control‐IQ algorithm that can be used simultaneously with the Exercise Activity feature. Conclusion: We believe that this expert guidance, with its practical flowcharts, can help simplify decision‐making for Control‐IQ users.
SN - 1462-8902
SN - 1463-1326
ER -